In May, 2025, the World Health Assembly (WHA) will vote on re-establishing a mandate for WHO to address the health ...

Estimated energy requirements (EERs) are used every day for diverse purposes. In clinical care they provide the basis to plan ...

For more than 80 years, the US Government has invested in biomedical, clinical, and public health research, making it a world leader in science and cutting-edge advances in health. These discoveries ...

New health data regulations promise to empower patients and help research, but can they overcome difficulties in ...

Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer and the fourth leading cause of cancer-related death, has a 5-year survival rate of less than 10%.1 The impact of pancreatic ...

Mexico's type 2 diabetes crisis, with a prevalence of 16·9%, has made the country a focal point for fiscal policies targeting ...

Colombia's progressive drug policy reforms include the prioritisation of harm reduction, but campaigners fear advances are at risk. Jacqui Thornton reports.

Treatment-resistant schizophrenia is a disabling illness, affecting approximately 8 million people worldwide with profound ...

Many African countries have long relied on overseas development aid to implement health programmes. Unfortunately, this aid ...

The use of digital health technology (DHT) is increasing worldwide. Clinical trials assessing available health tools for the ...

We evaluated the effects of digital health technologies (DHTs) on women's health, empowerment, and gender equality, using the ...

Randomised controlled trials are the gold standard to assess the effectiveness and safety of clinical interventions; however, ...